| Dr Robert Eugene Curry, MD | |
|
1374 E Alluvial Ave, Fresno, CA 93720-2608 | |
| (559) 981-2600 | |
| (559) 981-2610 |
| Full Name | Dr Robert Eugene Curry |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 55 Years |
| Location | 1374 E Alluvial Ave, Fresno, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033205539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | G24344 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Clovis Community Medical Center | Clovis, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Foundation Medical Group | 0345406294 | 263 |
News Archive
VisionGate Inc., an in vitro diagnostics company that is developing a revolutionary, non-invasive test for the early detection of lung cancer and other applications, announced that positive results from a clinical study of its LuCED lung test will be highlighted in a poster presentation (Abstract #7547) during the American Society of Clinical Oncology (ASCO) 2014 Annual Meeting at McCormick Place in Chicago on Saturday, May 31, 1:15 to 5 p.m. in S Hall A2, poster board 155.
Mayo researchers collaborating with investigators at the University of Iowa, University of Connecticut and New York University (NYU) have discovered a molecular mechanism that controls energy expenditure in muscles and helps determine body weight. Researchers say this could lead to a new medical approach in treating obesity.
R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.
Cell Therapeutics, Inc., announced today that it has completed its acquisition gaining world-wide rights to S*BIO Pte Ltd.'s pacritinib.
› Verified 3 days ago
| Entity Name | Community Foundation Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811258510 PECOS PAC ID: 0345406294 Enrollment ID: O20120723000387 |
News Archive
VisionGate Inc., an in vitro diagnostics company that is developing a revolutionary, non-invasive test for the early detection of lung cancer and other applications, announced that positive results from a clinical study of its LuCED lung test will be highlighted in a poster presentation (Abstract #7547) during the American Society of Clinical Oncology (ASCO) 2014 Annual Meeting at McCormick Place in Chicago on Saturday, May 31, 1:15 to 5 p.m. in S Hall A2, poster board 155.
Mayo researchers collaborating with investigators at the University of Iowa, University of Connecticut and New York University (NYU) have discovered a molecular mechanism that controls energy expenditure in muscles and helps determine body weight. Researchers say this could lead to a new medical approach in treating obesity.
R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.
Cell Therapeutics, Inc., announced today that it has completed its acquisition gaining world-wide rights to S*BIO Pte Ltd.'s pacritinib.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Eugene Curry, MD 1374 E Alluvial Ave, Fresno, CA 93720-2608 Ph: (559) 981-2600 | Dr Robert Eugene Curry, MD 1374 E Alluvial Ave, Fresno, CA 93720-2608 Ph: (559) 981-2600 |
News Archive
VisionGate Inc., an in vitro diagnostics company that is developing a revolutionary, non-invasive test for the early detection of lung cancer and other applications, announced that positive results from a clinical study of its LuCED lung test will be highlighted in a poster presentation (Abstract #7547) during the American Society of Clinical Oncology (ASCO) 2014 Annual Meeting at McCormick Place in Chicago on Saturday, May 31, 1:15 to 5 p.m. in S Hall A2, poster board 155.
Mayo researchers collaborating with investigators at the University of Iowa, University of Connecticut and New York University (NYU) have discovered a molecular mechanism that controls energy expenditure in muscles and helps determine body weight. Researchers say this could lead to a new medical approach in treating obesity.
R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.
Cell Therapeutics, Inc., announced today that it has completed its acquisition gaining world-wide rights to S*BIO Pte Ltd.'s pacritinib.
› Verified 3 days ago
Dr. Roydon Glen Fredrick Steinke, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6327 N Fresno St, Suite 101, Fresno, CA 93710 Phone: 559-435-5278 Fax: 559-435-7195 | |
Ms. Patricia Kay Felton, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7050 N Recreation Ave, #102, Fresno, CA 93720 Phone: 559-322-2900 Fax: 559-322-2901 | |
Pamela Louise Emeney, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2210 E Illinois Ave Ste 408, Fresno, CA 93701 Phone: 559-443-2694 Fax: 559-443-2696 | |
Mrs. Kim I Morris, N.P. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2210 E Illinois Ave Ste 505, Fresno, CA 93701 Phone: 559-266-8989 Fax: 559-266-8994 | |
Mr. Paul Madsen, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 290 N Wayte Ln, Fresno, CA 93701 Phone: 559-459-5755 Fax: 559-459-4453 | |
Elaine Winifred Morris, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1752 W Calimyrna Ave Apt B, Fresno, CA 93711 Phone: 559-451-0721 |